TipRanks on MSN

Cynata Therapeutics Secures $1.7 Million R&D Tax Refund to Boost Cell Therapy Development

Cynata Therapeutics Limited ( ($AU:CYP) ) has issued an announcement. Cynata Therapeutics Limited announced it received a $1.7 million R&D Tax ...

Cynata Therapeutics Receives $1.7 Million R&D Tax Incentive Refund

Cynata Therapeutics Limited (ASX: CYP), a clinical-stage biotechnology company specialising in cell therapeutics, announced ...
Reuters

Bristol Myers buys Orbital Therapeutics for $1.5 billion in cell therapy push

Oct 10 (Reuters) - Drugmaker Bristol Myers Squibb (BMY.N), opens new tab said on Friday it will acquire privately held cell therapy developer Orbital Therapeutics for $1.5 billion in cash, aiming to ...